Vitamin D regulates 175 genes (in 8 categories)

The master catalog of genes regulated by calcitriol and vitamin D receptor signaling

Cladua AI deep Research - April 2026

Calcitriol (1,25-dihydroxyvitamin D₃) directly or indirectly regulates over 200 genes through the vitamin D receptor (VDR), collectively governing calcium homeostasis, immune defense, cancer suppression, cardiovascular protection, metabolism, and brain function. This report compiles 175 VDR-regulated genes ranked by health importance, drawn from VDR ChIP-seq studies (Ramagopalan et al., Heikkinen et al., Meyer et al., Carlberg lab), transcriptomic datasets, and decades of molecular endocrinology research. The table below represents the most comprehensive available synthesis of how calcitriol's genomic actions translate into specific health benefits across virtually every organ system.

The scope of VDR's genomic reach is remarkable. ChIP-seq studies have identified 2,776 to 5,000+ VDR binding sites depending on cell type, with at least 700 genes showing direct, rapid transcriptional responses. Calcitriol simultaneously enhances antimicrobial killing while dampening autoimmune inflammation, promotes cancer cell death while protecting normal DNA, and strengthens bones while preventing vascular calcification. This report catalogs these actions gene by gene.


Eight parallel mechanisms create an integrated defense system

What makes calcitriol's gene regulatory program so medically significant is not any single gene but the coordinated, multi-pathway architecture of its actions. Eight distinct mechanistic themes emerge from this 175-gene catalog:

The antimicrobial-tolerogenic paradox is the most elegant feature. Calcitriol simultaneously upregulates pathogen-killing molecules (CAMP, DEFB4A, NOD2) while suppressing the inflammatory cytokines (TNF, IL-6, IL-17A, IFNG) and promoting tolerance mediators (FOXP3, IL-10, CTLA4). No synthetic drug achieves this dual action. The system effectively says: kill the pathogen, but do not damage the host.

The calcium transport cassette operates as a complete unit. TRPV6 opens the apical door, S100G/CALB1 shuttle calcium across the cell, and ATP2B1/SLC8A1 push it out the basolateral side. Calcitriol induces every component simultaneously, while negative feedback through CYP24A1, CYP27B1 suppression, and FGF23 induction prevents overcorrection.

The multi-layered anti-cancer program attacks malignancy from eight angles simultaneously: cell cycle arrest (p21, p27, p15 up; cyclin D1, Myc down), apoptosis promotion (BAX up, BCL-2 down), DNA repair (BRCA1, DDB2, XPC), EMT suppression (E-cadherin up, Snail down), anti-angiogenesis (VEGF down, THBS1 up), Wnt antagonism (DKK1, SFRPs), prostaglandin suppression (COX-2 down, 15-PGDH up), and detoxification (CYP3A4, SULT2A1, NRF2 cascade). This redundancy explains why single oncogene mutations cannot overcome vitamin D's protective effects.

The RAAS suppression cascade mirrors pharmaceutical interventions. Calcitriol suppresses renin (the ACE inhibitor principle), reduces angiotensin II receptors (the ARB principle), and upregulates the protective ACE2/angiotensin(1-7) arm, while enhancing eNOS for nitric oxide-mediated vasodilation — a comprehensive cardiovascular protection program.

The insulin axis is regulated end-to-end: β-cell insulin production (INS, PDX1, MAFA), insulin receptor expression (INSR), downstream signaling (IRS1, IRS2), and glucose transporter deployment (GLUT4). This makes vitamin D status a modifiable factor across the entire diabetes spectrum.

Calcium homeostasis and skeletal integrity: the foundational genes

The oldest and best-characterized VDR targets control mineral metabolism. Without these genes' regulation, rickets, osteomalacia, hypocalcemic tetany, and death would follow. Calcitriol orchestrates a complete calcium transport apparatus — apical entry channels, intracellular shuttles, and basolateral pumps — in both intestine and kidney, while simultaneously regulating phosphate balance and bone remodeling through endocrine feedback loops involving PTH, FGF23, and Klotho.

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
1 TRPV6 Transient receptor potential vanilloid 6 Rate-limiting apical calcium channel in intestinal epithelium. Upregulation is essential for active dietary calcium absorption, preventing rickets in children and osteomalacia/osteoporosis in adults. Most important single gene for calcium homeostasis.
2 CYP24A1 24-Hydroxylase Most potently induced VDR target. Catabolizes calcitriol and 25(OH)D, creating the critical negative feedback loop that prevents vitamin D toxicity and lethal hypercalcemia.
3 PTH Parathyroid hormone Direct suppression via negative VDRE prevents secondary hyperparathyroidism, reducing excessive bone resorption. Calcitriol analogs are standard therapy for hyperparathyroidism in chronic kidney disease.
4 CYP27B1 1α-Hydroxylase Negative feedback suppression prevents overproduction of active calcitriol, maintaining calcium-phosphate homeostasis and preventing hypercalcemia.
5 VDR Vitamin D receptor Positive autoregulation amplifies tissue sensitivity to calcitriol, ensuring adequate responsiveness in intestine, bone, kidney, and immune cells.
6 CALB1 Calbindin-D28k Intracellular calcium shuttle protein in kidney distal tubule and brain. Facilitates renal calcium reabsorption and provides neuroprotection by buffering intracellular calcium.
7 TRPV5 Transient receptor potential vanilloid 5 Apical calcium entry channel in kidney distal tubule. Upregulation promotes renal calcium reabsorption, reducing urinary calcium loss and maintaining serum calcium.
8 S100G Calbindin-D9k Intracellular calcium-buffering protein in intestinal enterocytes. Shuttles calcium across the cell during transcellular absorption, preventing toxic intracellular calcium spikes.
9 ATP2B1 Plasma membrane Ca²⁺ ATPase (PMCA1) Basolateral calcium pump completing transcellular calcium transport. Extrudes calcium into blood from intestinal and renal epithelial cells.
10 SLC8A1 Na⁺/Ca²⁺ exchanger (NCX1) Basolateral sodium-calcium exchanger working alongside PMCA to complete calcium extrusion into the bloodstream from absorptive cells.
11 FGF23 Fibroblast growth factor 23 Stimulates this phosphaturic hormone from osteocytes, creating a bone-kidney endocrine axis that promotes renal phosphate excretion and prevents hyperphosphatemia.
12 CASR Calcium-sensing receptor Enhances parathyroid gland sensitivity to serum calcium, improving PTH suppression and tightening calcium homeostatic control.
13 KL Klotho Essential FGF23 co-receptor and anti-aging factor. Upregulation enhances phosphate regulation, protects against vascular calcification, and activates longevity-associated pathways.
14 SLC34A2 NaPi-IIb (intestinal) Sodium-phosphate cotransporter mediating active dietary phosphate absorption, ensuring adequate phosphate for bone mineralization, ATP synthesis, and DNA.
15 CLDN2 Claudin 2 Tight junction protein forming paracellular cation channels in intestine. Enhances passive calcium absorption, complementing the transcellular pathway after meals.
16 CLDN12 Claudin 12 Additional tight junction protein increasing paracellular calcium permeability in the intestine, providing a secondary passive absorption route.
17 LRP2 Megalin Endocytic receptor in kidney proximal tubule that reabsorbs the 25(OH)D-DBP complex from urine, conserving circulating vitamin D stores.
18 CUBN Cubilin Co-receptor with megalin for renal reabsorption of vitamin D-binding protein complex, preventing urinary vitamin D loss.
19 SLC34A1 NaPi-IIa (renal) Indirectly downregulated via FGF23 induction, promoting renal phosphate excretion to prevent hyperphosphatemia and ectopic calcification.
20 PHEX Phosphate-regulating endopeptidase Regulates phosphate metabolism in bone; upregulation promotes proper mineralization. Loss-of-function causes X-linked hypophosphatemic rickets.
21 BGLAP Osteocalcin Major non-collagenous bone protein with a well-characterized VDRE. Promotes hydroxyapatite binding and bone mineralization; also acts as an endocrine hormone improving glucose metabolism and energy homeostasis.
22 SPP1 Osteopontin Multifunctional bone matrix protein directly induced via VDRE. Regulates osteoclast attachment, hydroxyapatite crystal growth, and bone remodeling; also modulates immune responses.
23 TNFSF11 RANKL Essential osteoclast differentiation cytokine. Calcitriol-driven RANKL induction enables bone resorption to release skeletal calcium when needed and maintain normal bone turnover.
24 ALPL Alkaline phosphatase Hydrolyzes pyrophosphate (mineralization inhibitor) to generate inorganic phosphate, promoting hydroxyapatite deposition in bone matrix. Deficiency causes hypophosphatasia.
25 RUNX2 Runt-related transcription factor 2 Master transcription factor for osteoblast differentiation. Drives commitment of mesenchymal stem cells to bone-forming lineage and activates downstream bone matrix genes.
26 TNFRSF11B Osteoprotegerin (OPG) Decoy receptor for RANKL. Downregulation shifts RANKL/OPG ratio to enable physiological bone resorption and remodeling.
27 IBSP Bone sialoprotein Nucleates hydroxyapatite crystal formation during mineralization. Direct VDR target promoting initiation of bone mineral deposition.
28 LRP5 LDL receptor-related protein 5 Wnt/β-catenin co-receptor; upregulation enhances the major anabolic bone formation pathway. Mutations cause high bone mass or osteoporosis-pseudoglioma syndrome.
29 DMP1 Dentin matrix protein 1 Osteocyte protein critical for mineralization and phosphate homeostasis. Mutations cause autosomal recessive hypophosphatemic rickets.
30 MEPE Matrix extracellular phosphoglycoprotein SIBLING protein regulating phosphate handling and bone mineralization through its ASARM peptide, fine-tuning mineral ion balance.
31 COL1A1 Collagen type I alpha 1 At pharmacological doses, suppresses collagen synthesis to shift osteoblast activity from matrix production toward mineralization and remodeling phases.
32 SLC34A3 NaPi-IIc (renal) Indirectly reduced via FGF23, promoting phosphate excretion especially during growth to prevent excessive calcium-phosphate product.

Immune defense and inflammatory control: the dual-action network

Calcitriol's immune regulation is arguably its most medically significant non-skeletal function. The system exhibits an elegant duality: calcitriol simultaneously upregulates antimicrobial killing mechanisms while suppressing inflammatory and autoimmune pathways. This means vitamin D boosts the ability to fight infections while preventing the immune system from attacking the body's own tissues — a combination no synthetic drug has replicated.

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
33 CAMP Cathelicidin (LL-37) The most celebrated VDR immune target. Direct VDRE-mediated induction in monocytes/macrophages produces LL-37, which kills M. tuberculosis, MRSA, influenza, and fungi. Also promotes wound healing. Central to the vitamin D–infection axis discovered by Liu et al. (2006, Science).
34 NFKBIA IκBα (NF-κB inhibitor alpha) Master anti-inflammatory mechanism. Sequesters NF-κB in the cytoplasm, broadly suppressing transcription of TNF, IL-6, IL-1β, IL-8, adhesion molecules, and other pro-inflammatory genes across virtually all inflammatory conditions.
35 IL12B Interleukin 12 subunit p40 Shared subunit of both IL-12 and IL-23. Suppression simultaneously inhibits Th1 (IL-12-driven) and Th17 (IL-23-driven) pathways — a powerful dual anti-inflammatory mechanism relevant to MS, T1D, RA, and IBD.
36 FOXP3 Forkhead box P3 Master regulator of regulatory T cells (Tregs). Induction promotes immune tolerance, preventing autoimmune disease, transplant rejection, and maintaining gut homeostasis.
37 IL10 Interleukin 10 Master anti-inflammatory cytokine. Upregulation suppresses Th1/Th17 effector responses, limits tissue damage during infection, and maintains mucosal immune tolerance.
38 TNF Tumor necrosis factor Suppression reduces systemic inflammation, cachexia, and tissue destruction in rheumatoid arthritis, IBD, psoriasis, and sepsis. TNF is the target of the most commercially successful class of biologic drugs.
39 IL6 Interleukin 6 Reduces acute-phase responses (CRP, fibrinogen), Th17 differentiation, and chronic inflammation. Lowers cardiovascular risk from chronic inflammatory states.
40 IFNG Interferon gamma Shifts Th1/Th2 balance away from Th1 dominance, protecting against Th1-driven autoimmune diseases including multiple sclerosis, type 1 diabetes, and Crohn's disease.
41 IL17A Interleukin 17A Suppresses Th17-driven neutrophilic inflammation and tissue damage. Relevant to psoriasis, ankylosing spondylitis, MS, and RA — diseases treated with anti-IL-17 biologics.
42 IL1B Interleukin 1 beta Suppresses potent pro-inflammatory cytokine at transcriptional level and via NLRP3 inflammasome inhibition. Benefits gout, atherosclerosis, and autoinflammatory conditions.
43 NLRP3 NLRP3 inflammasome Suppresses inflammasome assembly and caspase-1 activation, reducing IL-1β and IL-18 release. Protects against gout, atherosclerosis, type 2 diabetes, and Alzheimer's disease.
44 DEFB4A Beta-defensin 2 (HBD-2) Broad-spectrum antimicrobial peptide induced synergistically with NOD2 signaling. Kills gram-negative bacteria and Candida at mucosal surfaces of gut, lung, and skin.
45 NOD2 Nucleotide-binding oligomerization domain 2 Intracellular pattern recognition receptor sensing bacterial peptidoglycan. Creates a vitamin D–NOD2–defensin antimicrobial circuit critical for gut immunity. Mutations cause Crohn's disease.
46 HAMP Hepcidin Direct VDRE-mediated suppression reduces hepcidin, increasing iron bioavailability via ferroportin. Corrects anemia of chronic disease/inflammation in CKD, IBD, and chronic infections.
47 IL23A Interleukin 23 p19 Suppresses IL-23, the cytokine maintaining Th17 cell phenotype and driving chronic inflammation in psoriasis, IBD, and spondyloarthritis.
48 IL17F Interleukin 17F Reduces mucosal inflammation and neutrophil recruitment, complementing IL-17A suppression in Th17-driven diseases.
49 IL12A Interleukin 12 p35 Reduces IL-12p70 heterodimer, impairing Th1 polarization of naïve CD4+ T cells and dampening cell-mediated autoimmune responses.
50 TSC22D3 GILZ (glucocorticoid-induced leucine zipper) Inhibits NF-κB and AP-1, suppresses pro-inflammatory cytokines, promotes tolerogenic dendritic cells. Provides glucocorticoid-like anti-inflammatory effects without metabolic side effects.
51 DUSP1 Dual specificity phosphatase 1 (MKP-1) Dephosphorylates and inactivates p38 MAPK, JNK, and ERK, broadly attenuating TLR-mediated and cytokine-receptor inflammatory cascades.
52 CTLA4 Cytotoxic T-lymphocyte associated protein 4 Immune checkpoint molecule on T cells. Competes with CD28 for B7 ligands, delivering inhibitory signals that maintain peripheral tolerance and prevent autoimmune tissue destruction.
53 CD274 PD-L1 (programmed death ligand 1) Engages PD-1 on effector T cells to induce anergy/exhaustion, suppressing autoreactive T cell responses. Protective in autoimmunity and transplant settings.
54 IL2 Interleukin 2 VDR directly interferes with NFAT/AP-1 at the IL-2 promoter, restraining clonal expansion of effector T cells while preserving Treg function. Prevents autoimmune flares.
55 SOCS1 Suppressor of cytokine signaling 1 Inhibits IFN-γ/STAT1 and IL-4/STAT6 signaling, providing a critical brake on cytokine amplification loops and excessive Th1/Th2 responses.
56 SOCS3 Suppressor of cytokine signaling 3 Specifically inhibits IL-6/STAT3 signaling, attenuating Th17 differentiation and IL-6-driven inflammatory responses including cytokine storm.
57 TNFAIP3 A20 (TNF alpha induced protein 3) Deubiquitinating enzyme that terminates NF-κB activation downstream of TLRs, TNF-R, and IL-1R. Loss-of-function causes severe autoinflammatory disease.
58 TGFB1 Transforming growth factor beta 1 Broad immunosuppressive cytokine promoting Treg differentiation (synergizes with FOXP3 induction), tissue repair, and mucosal homeostasis.
59 THBD Thrombomodulin Activates protein C anticoagulant pathway, providing anti-coagulant and anti-inflammatory protection. Prevents DIC and vascular inflammation during sepsis.
60 CCL2 MCP-1 (monocyte chemoattractant protein 1) Reduces monocyte/macrophage recruitment to inflammatory sites, protecting against atherosclerotic plaque formation, nephritis, and adipose tissue inflammation.
61 CXCL10 IP-10 Reduces recruitment of CXCR3+ Th1/CD8+ T cells to inflammatory sites, decreasing Th1-mediated tissue damage in autoimmune thyroiditis, hepatitis, and transplant rejection.
62 DEFB103 Beta-defensin 3 (HBD-3) Broad-spectrum antimicrobial active against gram-positive and gram-negative bacteria and fungi at epithelial barriers including skin and oral mucosa.
63 PI3 Elafin (peptidase inhibitor 3) Dual-function molecule: antimicrobial peptide and serine protease inhibitor that protects tissues from neutrophil elastase damage during inflammation.
64 CD14 Monocyte differentiation antigen Improves pathogen recognition and phagocytic capacity while concurrent TLR4 downregulation prevents excessive inflammatory signaling — balanced innate immune tuning.
65 TLR2 Toll-like receptor 2 Post-activation downregulation prevents sustained pro-inflammatory signaling and hyperinflammation while antimicrobial peptide production continues via other VDR targets.
66 TLR4 Toll-like receptor 4 Reduces cellular sensitivity to LPS, dampening endotoxemia, gram-negative sepsis, and chronic low-grade inflammation associated with metabolic syndrome.
67 TREM1 Triggering receptor on myeloid cells 1 Attenuates the TLR amplification loop of innate inflammation, reducing risk of cytokine storm and excessive tissue damage during infections and sepsis.

Anti-cancer mechanisms: cell cycle arrest, apoptosis, and genomic protection

Calcitriol's anti-cancer program operates through at least eight parallel mechanisms: cell cycle arrest (p21/p27/p15 induction, cyclin D1/Myc suppression), pro-apoptotic shifting (BAX up, BCL-2 down), DNA repair enhancement (BRCA1, DDB2, XPC), anti-metastatic action (E-cadherin up, Snail down), anti-angiogenesis (VEGF down, thrombospondin up), Wnt pathway antagonism (DKK1, SFRPs), prostaglandin suppression (COX-2 down, 15-PGDH up), and comprehensive detoxification (CYP3A4, SULT2A1, NRF2 cascade). This multi-layered approach explains why no single cancer gene mutation can fully overcome vitamin D's protective effects.

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
68 CDKN1A p21 (cyclin-dependent kinase inhibitor 1A) The most robust anti-proliferative VDR target. Direct VDRE-mediated induction inhibits cyclin-CDK complexes, causing G1 arrest in colon, breast, prostate, and virtually all cancer types tested.
69 PTEN Phosphatase and tensin homolog Tumor suppressor that antagonizes PI3K/Akt survival signaling. Upregulation suppresses oncogenic cell survival, proliferation, and metabolic reprogramming in prostate and breast cancers.
70 MYC c-Myc proto-oncogene Suppression of this master proliferation regulator reduces expression of cell cycle genes, ribosome biogenesis, and metabolic reprogramming. Key mechanism in colon cancer, leukemia, and breast cancer.
71 BAX BCL2-associated X protein Shifts BAX/BCL-2 ratio toward apoptosis. BAX forms mitochondrial pores releasing cytochrome c, activating caspase cascades to eliminate damaged/transformed cells.
72 BCL2 B-cell lymphoma 2 Removes the key anti-apoptotic brake on mitochondrial membrane permeabilization. Combined with BAX upregulation, sensitizes cancer cells to programmed cell death.
73 BRCA1 Breast cancer 1 Induced via functional VDRE in its promoter. Essential for homologous recombination DNA repair. The vitamin D–BRCA1 axis is particularly relevant to breast and ovarian cancer prevention.
74 CCND1 Cyclin D1 Reduces this essential G1 cyclin both transcriptionally and post-translationally. Cooperates with p21/p27 upregulation to enforce G0/G1 arrest. Overexpressed in breast, colon, and many cancers.
75 IGFBP3 Insulin-like growth factor binding protein 3 Sequesters IGF-1/IGF-2, blocking PI3K/Akt and MAPK survival signaling. Also has IGF-independent pro-apoptotic effects in prostate and breast cancers.
76 CDH1 E-cadherin Preserves epithelial cell-cell adhesion and blocks epithelial-to-mesenchymal transition (EMT). E-cadherin loss is a hallmark of invasion and metastasis in colon, breast, and other carcinomas.
77 GADD45A Growth arrest and DNA damage inducible alpha Dual function: promotes G2/M cell cycle arrest and participates in DNA repair via PCNA interaction. Provides a critical checkpoint against genomic instability.
78 CDKN1B p27 (cyclin-dependent kinase inhibitor 1B) Stabilized by calcitriol (reduced proteasomal degradation via SKP2 downregulation). Inhibits cyclin E–CDK2, reinforcing G1 arrest in prostate, breast, and colon cancers.
79 DDB2 Damage-specific DNA binding protein 2 Key nucleotide excision repair (NER) component recognizing UV-induced DNA damage. Upregulation enhances DNA repair, providing photoprotection and reducing skin cancer risk.
80 XPC Xeroderma pigmentosum group C Primary sensor of helix-distorting DNA lesions in global genome NER. Works with DDB2 to accelerate removal of DNA damage, reducing mutagenesis and cancer initiation.
81 PTGS2 COX-2 (prostaglandin-endoperoxide synthase 2) Suppresses inducible PGE2 synthesis. PGE2 promotes tumor proliferation, angiogenesis, and immune evasion. COX-2 suppression mirrors the chemopreventive effects of NSAIDs, especially in colorectal cancer.
82 HPGD 15-PGDH (15-hydroxyprostaglandin dehydrogenase) Catabolizes and inactivates PGE2. Combined with COX-2 suppression, creates a two-pronged reduction in pro-tumorigenic prostaglandin levels — a key colorectal cancer prevention mechanism.
83 SNAI1/SNAI2 Snail/Slug Represses master EMT transcription factors that would otherwise suppress E-cadherin and promote mesenchymal gene expression, preventing cancer cell invasion and metastatic dissemination.
84 VEGFA Vascular endothelial growth factor A Suppresses the major pro-angiogenic signal in tumor cells, restricting blood vessel formation needed for tumor growth beyond 1-2 mm. Demonstrated in prostate, breast, and colon cancer.
85 THBS1 Thrombospondin 1 Potent endogenous angiogenesis inhibitor. Activates TGF-β and induces endothelial cell apoptosis via CD36, cutting off tumor blood supply.
86 DKK1 Dickkopf-1 Secreted Wnt antagonist binding LRP5/6. Blocks aberrant Wnt/β-catenin signaling — the most frequently mutated oncogenic pathway in colorectal cancer — reducing nuclear β-catenin and its target genes c-Myc and cyclin D1.
87 SFRP1 Secreted frizzled-related protein 1 Decoy receptor sequestering Wnt ligands from Frizzled receptors. Frequently silenced by methylation in cancers; vitamin D-mediated restoration suppresses Wnt-driven proliferation.
88 SFRP2 Secreted frizzled-related protein 2 Additional Wnt antagonist providing redundant suppression of aberrant Wnt signaling. Particularly protective in colorectal cancer.
89 KLF4 Kruppel-like factor 4 Promotes cellular differentiation, induces p21, and suppresses oncogenic pathways. Acts as tumor suppressor driving differentiation toward mature, non-proliferative phenotype in colorectal cancer.
90 CST5 Cystatin D Cysteine protease inhibitor suppressing cathepsin-mediated matrix degradation and invasion. Direct VDR target with tumor suppressor properties in colon cancer; also inhibits Wnt signaling.
91 BCL2L11 BIM (BH3-only protein) Potent pro-apoptotic protein that neutralizes anti-apoptotic BCL-2 family members and directly activates BAX/BAK. Enhances apoptotic response in SCC and breast cancer.
92 CDKN2B p15 (cyclin-dependent kinase inhibitor 2B) Specifically inhibits CDK4/CDK6, blocking Rb phosphorylation and G1-to-S transition. Demonstrated in myeloid leukemia where vitamin D promotes differentiation.
93 RB1 Retinoblastoma protein Maintained in active hypophosphorylated state by CDK inhibitor upregulation and cyclin downregulation, sequestering E2F to block S-phase entry.
94 E2F1 E2F transcription factor 1 Functionally repressed via Rb sequestration, preventing expression of DNA synthesis genes (thymidylate synthase, DNA polymerase α, DHFR).

Cardiovascular protection through RAAS suppression and endothelial health

Calcitriol's cardiovascular benefits center on suppression of the renin-angiotensin-aldosterone system (RAAS) — the same pathway targeted by ACE inhibitors and ARBs, two of the most prescribed drug classes worldwide. VDR-null mice develop cardiac hypertrophy and hypertension, confirming the physiological importance of these genomic actions.

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
95 REN Renin Directly suppressed via negative VDRE (Li et al., 2002). Reduces RAAS activation, lowering blood pressure and decreasing cardiac and renal fibrosis. VDR-null mice show markedly elevated renin.
96 NOS3 Endothelial nitric oxide synthase (eNOS) Increases NO bioavailability in endothelial cells, promoting vasodilation, improving endothelial function, and reducing platelet aggregation and leukocyte adhesion.
97 ACE2 Angiotensin-converting enzyme 2 Converts angiotensin II to vasodilatory angiotensin(1-7), shifting RAAS balance toward cardioprotection. Also relevant to COVID-19 pathophysiology.
98 AGTR1 Angiotensin II receptor type 1 Reduces AT1R-mediated vasoconstriction, aldosterone secretion, vascular inflammation, and fibrosis.
99 ACE Angiotensin-converting enzyme Reduces angiotensin II production, decreasing vasoconstriction, oxidative stress, and inflammatory signaling.
100 EDN1 Endothelin-1 Suppresses potent vasoconstrictor in endothelial and vascular smooth muscle cells, reducing cardiac remodeling and vascular inflammation.
101 MMP9 Matrix metalloproteinase 9 Suppresses matrix degradation in macrophages and vascular smooth muscle, reducing atherosclerotic plaque instability, aortic aneurysm risk, and pathological vascular remodeling.
102 AGT Angiotensinogen Reduces substrate availability for angiotensin II production, further dampening RAAS activation.
103 NPPA Natriuretic peptide A (ANP) Normalization reflects reduced cardiac wall stress and improved cardiac function.
104 NPPB Natriuretic peptide B (BNP) Reduction indicates alleviated cardiac volume/pressure overload and improved heart failure status.
105 SERPINE1 PAI-1 (plasminogen activator inhibitor 1) Reduces thrombotic risk by decreasing the primary inhibitor of fibrinolysis. Protective against venous thromboembolism and atherothrombosis.

Metabolic regulation: insulin secretion, sensitivity, and glucose control

Calcitriol regulates the entire insulin signaling axis — from pancreatic β-cell insulin production to peripheral tissue insulin sensitivity — making vitamin D deficiency a modifiable risk factor for both type 1 and type 2 diabetes.

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
106 INS Insulin Enhances insulin gene transcription in β-cells via a VDRE in the INS promoter (Maestro et al., 2003). Improves glucose-stimulated insulin secretion and glycemic control.
107 INSR Insulin receptor Increases insulin receptor expression (Maestro et al., 2000), enhancing cellular insulin sensitivity and glucose uptake in target tissues.
108 PDX1 Pancreatic and duodenal homeobox 1 Master β-cell transcription factor. Promotes β-cell development, survival, and insulin transcription.
109 MAFA MAF bZIP transcription factor A Critical transcription factor for glucose-stimulated insulin secretion in mature β-cells. Enhances the coupling of glucose sensing to insulin release.
110 SLC2A4 GLUT4 (glucose transporter type 4) Increases insulin-stimulated glucose uptake in skeletal muscle and adipose tissue, directly improving glucose disposal.
111 IRS1 Insulin receptor substrate 1 Enhances downstream insulin signaling cascade, improving glucose metabolism and insulin sensitivity.
112 IRS2 Insulin receptor substrate 2 Critical for β-cell survival and hepatic insulin signaling. Enhances β-cell mass and function.
113 ADIPOQ Adiponectin Insulin-sensitizing, anti-inflammatory, and anti-atherogenic adipokine. Enhances fatty acid oxidation and improves metabolic syndrome.
114 PPARG PPARγ Promotes insulin sensitization and healthy adipocyte differentiation, improving lipid metabolism and reducing insulin resistance.
115 LEP Leptin Reduces hyperleptinemia and leptin resistance, improving appetite regulation and metabolic homeostasis.
116 PCK1 Phosphoenolpyruvate carboxykinase 1 Reduces hepatic gluconeogenesis, lowering fasting glucose in type 2 diabetes and insulin resistance.
117 CYP7A1 Cholesterol 7α-hydroxylase Modulates bile acid synthesis and cholesterol metabolism. Suppression via VDR-SHP axis regulates enterohepatic circulation.
118 NR0B2 SHP (small heterodimer partner) Transcriptional repressor of bile acid synthesis genes. Protects against bile acid toxicity and modulates lipid/cholesterol metabolism.
119 HMGCR HMG-CoA reductase Rate-limiting enzyme in cholesterol synthesis. Downregulation reduces endogenous cholesterol production — the same target as statin drugs.

Neuroprotection: neurotrophins, neurotransmitters, and anti-Alzheimer's actions

VDR is expressed throughout the brain, and calcitriol regulates a remarkable constellation of neurological genes spanning neurotrophic factor production, neurotransmitter synthesis, and amyloid clearance. The TPH2 regulation is particularly notable — Patrick and Ames (2014) identified a VDRE in the TPH2 promoter, directly linking vitamin D to brain serotonin production and mental health.

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
120 TPH2 Tryptophan hydroxylase 2 Rate-limiting enzyme for brain serotonin synthesis. Direct VDRE-mediated activation (Patrick & Ames, 2014, FASEB J). Increases brain serotonin, improving mood, social behavior, and executive function. Relevant to depression, anxiety, autism, and seasonal affective disorder.
121 NGF Nerve growth factor Promotes survival of cholinergic neurons, synaptic plasticity, and cognitive maintenance. Protects against Alzheimer's-related cholinergic degeneration.
122 GDNF Glial cell-derived neurotrophic factor Promotes survival and maintenance of dopaminergic neurons. Neuroprotective in Parkinson's disease models.
123 BDNF Brain-derived neurotrophic factor Enhances synaptic plasticity, learning, memory, and adult neurogenesis. Deficiency linked to depression, Alzheimer's, and cognitive decline.
124 TH Tyrosine hydroxylase Rate-limiting enzyme for dopamine synthesis. Enhances dopaminergic neurotransmission, supporting motor function, motivation, and reward circuits. Relevant to Parkinson's disease.
125 CHAT Choline acetyltransferase Increases acetylcholine synthesis, supporting memory, learning, and cognitive function. Addresses the cholinergic deficit central to Alzheimer's pathology.
126 APP Amyloid precursor protein Reduces APP expression and amyloid-β production, decreasing amyloid plaque burden — the pathological hallmark of Alzheimer's disease.
127 BACE1 Beta-secretase 1 Suppresses the enzyme that cleaves APP to generate amyloid-β42. Reduces Aβ generation, potentially slowing Alzheimer's disease progression.
128 GAD1 Glutamate decarboxylase 1 Enhances GABAergic inhibitory neurotransmission, critical for neuronal circuit balance. Relevant to epilepsy, schizophrenia, and autism.
129 NTF3 Neurotrophin 3 Supports survival and differentiation of developing neurons, particularly proprioceptive and sensory neurons.
130 SLC6A4 Serotonin transporter (SERT) Reduces serotonin reuptake, increasing synaptic serotonin availability — the same mechanism as SSRI antidepressants.
131 VGF VGF nerve growth factor inducible Neuropeptide precursor promoting synaptic plasticity, energy homeostasis, and neuroprotection. Reduced in Alzheimer's, depression, and Huntington's disease.
132 NOS1 Neuronal nitric oxide synthase Limits excessive NO/peroxynitrite production in pathological conditions, reducing oxidative neuronal damage in stroke, TBI, and neurodegeneration.

Detoxification, antioxidant defense, and cytoprotective cascades

Calcitriol activates all three phases of xenobiotic metabolism and the master antioxidant response, creating a comprehensive cellular defense system against environmental carcinogens, oxidative stress, and metabolic toxins.

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
133 NFE2L2 NRF2 (nuclear factor erythroid 2-related factor 2) Master transcription factor of the antioxidant response. Drives expression of glutathione S-transferases, NAD(P)H quinone oxidoreductase, and detoxification enzymes. Amplifies entire cellular antioxidant defense.
134 CYP3A4 Cytochrome P450 3A4 Major phase I enzyme metabolizing dietary carcinogens and xenobiotics in intestine and liver. Contains functional VDREs. Enhances first-pass carcinogen clearance, especially relevant to colon cancer prevention.
135 SOD2 Superoxide dismutase 2 (MnSOD) Mitochondrial antioxidant converting superoxide to hydrogen peroxide. Protects mitochondrial DNA and prevents oxidative damage driving genomic instability and cancer.
136 GPX1 Glutathione peroxidase 1 Selenoenzyme reducing hydrogen peroxide and lipid hydroperoxides. Reduces oxidative DNA damage, lipid peroxidation, and protein oxidation across all tissues.
137 HMOX1 Heme oxygenase 1 Degrades pro-oxidant free heme into antioxidant biliverdin, anti-inflammatory CO, and iron (sequestered by ferritin). Especially protective in colon where dietary heme is a cancer risk factor.
138 CAT Catalase Decomposes hydrogen peroxide into water and oxygen. Works with SOD2 and GPX1 to maintain redox balance and prevent oxidative mutagenesis.
139 TXNRD1 Thioredoxin reductase 1 Maintains the thioredoxin system in reduced state, critical for redox regulation, DNA synthesis support, and oxidative stress defense.
140 SULT2A1 Sulfotransferase 2A1 Phase II conjugation enzyme sulfonating bile acids and xenobiotics for elimination. Reduces exposure to tumor-promoting bile acid metabolites, especially in colorectal cancer prevention.
141 ABCB1 P-glycoprotein (MDR1) Phase III efflux transporter pumping xenobiotics and carcinogens out of cells. Contains VDREs. Reduces intracellular genotoxic compound accumulation.
142 ABCC2 MRP2 (multidrug resistance protein 2) Additional phase III efflux transporter in intestine and liver enhancing elimination of conjugated toxins and carcinogens.
143 ABCG2 BCRP (breast cancer resistance protein) Efflux transporter protecting stem cells and epithelial barriers from xenobiotic accumulation.
144 CYP2B6 Cytochrome P450 2B6 Phase I enzyme contributing to detoxification of drugs and environmental chemicals in liver.

Skin barrier, muscle function, and tissue-specific protective genes

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
145 FLG Filaggrin Essential for skin barrier integrity and natural moisturizing factor production. Deficiency causes atopic dermatitis and allergic sensitization.
146 IVL Involucrin Structural component of the cornified cell envelope, strengthening the skin's physical barrier against pathogens and allergens.
147 LOR Loricrin Major cornified envelope protein. Upregulation improves epidermal barrier strength and integrity.
148 TGM1 Transglutaminase 1 Crosslinks cornified envelope proteins (involucrin, loricrin), creating the covalent bonds that make the skin barrier mechanically robust.
149 KRT1 Keratin 1 Supports proper suprabasal keratinocyte differentiation and epidermal stratification.
150 KRT10 Keratin 10 Suprabasal keratin essential for normal epidermal differentiation and barrier formation.
151 MSTN Myostatin Negative regulator of muscle growth. Suppression promotes muscle hypertrophy, strength, and regeneration. Critical for preventing sarcopenia, cancer cachexia, and age-related muscle wasting.
152 MYOD1 Myogenic differentiation 1 Master transcription factor for skeletal muscle differentiation. Drives muscle repair and regeneration.
153 IGF1 Insulin-like growth factor 1 Promotes muscle protein synthesis, satellite cell proliferation, and muscle regeneration.
154 FOXO1 Forkhead box O1 Nuclear activity suppression prevents muscle protein degradation and atrophy by inhibiting atrogin-1/MuRF1 programs.
155 OCLN Occludin Tight junction protein maintaining epithelial barrier integrity in gut and other mucosal surfaces. Protects against "leaky gut" and pathogen translocation.
156 TJP1 ZO-1 (tight junction protein 1) Scaffolding protein anchoring tight junctions to the cytoskeleton. Strengthens epithelial barriers in intestine and other epithelia.
157 SLC40A1 Ferroportin The sole cellular iron exporter. Upregulated as a consequence of hepcidin suppression, increasing iron release from enterocytes and macrophages to correct anemia.
158 AQP2 Aquaporin 2 Renal collecting duct water channel. Upregulation supports proper water reabsorption and urine concentration.
159 HR Hairless Classical VDR target essential for hair follicle cycling. VDR mutations that disrupt HR interaction cause alopecia, demonstrating VDR-HR cooperation in hair biology.

Autophagy, epigenetics, and longevity-associated genes

Emerging research reveals calcitriol's regulation of cellular quality control and aging pathways, including autophagy for clearing damaged organelles, epigenetic modifiers controlling gene accessibility, and telomere maintenance enzymes. The SIRT1–FOXO3–TERT axis represents a longevity network directly enhanced by vitamin D signaling.

Rank Gene Full Name ↑/↓ How calcitriol regulation improves health
160 BECN1 Beclin 1 Key initiator of autophagosome formation (Yuk et al., 2009). Enhances autophagy for clearance of damaged organelles, misfolded proteins, and intracellular pathogens including M. tuberculosis.
161 ATG5 Autophagy related 5 Essential for autophagosome elongation and maturation. Improved autophagic flux clears damaged cellular components and intracellular bacteria.
162 ATG16L1 Autophagy related 16 like 1 Critical for intestinal epithelial defense and Paneth cell function. Variants are Crohn's disease risk factors; upregulation supports gut immune homeostasis.
163 SIRT1 Sirtuin 1 Master longevity regulator. NAD⁺-dependent deacetylase promoting DNA repair, mitochondrial biogenesis, and anti-inflammatory responses via FOXO3, p53, PGC-1α, and NF-κB deacetylation.
164 FOXO3 Forkhead box O3 Longevity gene identified in GWAS. Induces SOD2, catalase, and autophagy genes. Promotes DNA repair and oxidative stress resistance.
165 TERT Telomerase reverse transcriptase Maintains telomere length in normal and immune cells, delaying cellular senescence. Context-dependent: downregulated in cancer cells to limit proliferation.
166 PPARGC1A PGC-1α Master regulator of mitochondrial biogenesis. Enhances oxidative phosphorylation capacity, energy production, and metabolic fitness.
167 TFAM Mitochondrial transcription factor A Drives mitochondrial DNA transcription and replication. Supports mitochondrial mass and function, protecting against age-related mitochondrial decline.
168 NRF1 Nuclear respiratory factor 1 Transcription factor coordinating nuclear-encoded mitochondrial gene expression with mitochondrial biogenesis.
169 KDM6B JMJD3 (histone H3K27 demethylase) Removes repressive H3K27me3 marks, enabling transcription of calcitriol target genes. Epigenetic gatekeeper of VDR-mediated gene activation in immune cells.
170 TET2 Tet methylcytosine dioxygenase 2 DNA demethylase converting 5-methylcytosine to 5-hydroxymethylcytosine. Promotes active DNA demethylation and gene reactivation, relevant to tumor suppressor gene re-expression.
171 DNMT1 DNA methyltransferase 1 Reduces maintenance DNA methylation, potentially enabling re-expression of silenced tumor suppressor genes in cancer.
172 EZH2 Enhancer of zeste homolog 2 Polycomb component catalyzing repressive H3K27me3 marks. Downregulation reduces epigenetic silencing of tumor suppressors. Overexpressed in aggressive cancers.
173 PER2 Period circadian regulator 2 Core clock gene. Upregulation supports circadian rhythm integrity, which governs immune function, metabolism, DNA repair timing, and cancer susceptibility.
174 BMAL1 Brain and muscle ARNT-like 1 Master circadian transcription factor. Proper regulation supports metabolic rhythms, immune cycling, and sleep-wake homeostasis.
175 ALOX15 Arachidonate 15-lipoxygenase Generates specialized pro-resolving mediators (lipoxins, resolvins) from arachidonic acid. Promotes active resolution of inflammation rather than just suppression.

Conclusion

This catalog of 175 calcitriol-regulated genes reveals vitamin D not as a single-function nutrient but as a master genomic regulator operating through the VDR across virtually every organ system. The three most impactful regulatory domains are calcium/skeletal homeostasis (preventing rickets, osteoporosis, and hypocalcemic death), immune dual-regulation (enhancing antimicrobial defense while suppressing autoimmunity), and multi-pathway cancer suppression (attacking malignancy through at least eight independent mechanisms).

Several practical insights emerge. First, the sheer number of simultaneously regulated genes explains why observational studies consistently find vitamin D deficiency associated with diverse diseases — it is not confounding but biology. Second, the tissue-specific nature of VDR binding (2,776 sites in lymphoblastoid cells vs. 5,000+ in prostate cells) means calcitriol's gene targets vary by organ, explaining tissue-specific disease associations. Third, many of these genes show dose-response relationships, with physiological versus pharmacological calcitriol concentrations sometimes producing different effects — a critical consideration for supplementation strategy. Finally, the emerging categories of autophagy, epigenetic, circadian, and mitochondrial gene regulation suggest that vitamin D's full genomic impact is still being discovered, with new VDR targets identified in every major ChIP-seq study published.


Related in Vitamin D Life

How many genes?